journal article·2021-01Open access

Implantation of nanofibrous silk scaffolds seeded with bone marrow stromal cells promotes spinal cord regeneration (6686 words)

Xin-Hong Wang, Xiao-Chen Tang, Xia Li, Jian-Zhong Qin, Wen-Tao Zhong, Peng Wu, Feng Zhang, Yi-Xin Shen, Ting-Ting Dai

Abstract

Spinal cord injury (SCI) is a common pathology often resulting in permanent loss of sensory, motor, and autonomic function. Numerous studies in which stem cells have been transplanted in biomaterial scaffolds into animals have demonstrated their considerable potential for recovery from SCI. In the present study, a three-dimensional porous silk fibroin (SF) scaffold with a mean pore size of approximately 383 μm and nanofibrous structure was fabricated, the silk scaffold enabling the enhanced attachment and proliferation of bone marrow stromal cells (BMSCs). Investigation of its therapeutic potential was conducted by implantation of the nanofibrous SF scaffold seeded with BMSCs into a transected spinal cord model. Recovery of the damaged spinal cord was significantly improved after 2 months, compared with a non-nanofibrous scaffold, in combination with decreased glial fibrillary acidic protein (GFAP) expression and improved axonal regeneration at the site of injury. Furthermore, elevated Basso-Beattie-Bresnahan (BBB) scores indicated greatly improved hindlimb movement. Together, these results demonstrate that transplantation of neural scaffolds consisting of nanofibrous SF and BMSCs is an attractive strategy for the promotion of functional recovery following SCI.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Silk-based biomaterials and applications · Nerve injury and regeneration · Electrospun Nanofibers in Biomedical Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Orthopedics, The Second Affiliated Hospital of Soochow University, Suzhou, China

Department of orthopedics, The Affiliated Huai'an Hospital of Xuzhou Medical University and The Second People's Hospital of Huai'an, Huai’an, China

Department of Orthopedics, Suzhou TCM Hospital Affiliated to Nanjing University of Chinese Medicine, Suzhou, China

Department of Orthopedics, Huai'an Fourth People's Hospital, Jiangsu, China

Department of Radiation Oncology, The Affiliated Huai’an No. 1 People’s Hospital of Nanjing Medical University, Huai’an, China

References (52)

Show source-provided references
1. 10.4103/0974-8237.18188010.4103/0974-8237.181880 ↗
2. Tan JW, Wang KY, Liao GJ, et al. Neuroprotective effect of methylprednisolone combined with placenta-derived mesenchymal stem cell in rabbit model of spinal cord injury. Int J Clin Exp Pathol. 2015;8(8):8976–8982.
3. 10.1038/nrdp.2017.1810.1038/nrdp.2017.18 ↗
4. 10.1093/neuros/nyw08010.1093/neuros/nyw080 ↗
5. 10.1016/bs.pbr.2016.11.01210.1016/bs.pbr.2016.11.012 ↗
6. 10.3390/cells710017310.3390/cells7100173 ↗
7. 10.1089/neu.2019.693910.1089/neu.2019.6939 ↗
8. 10.1016/j.biomaterials.2018.05.04910.1016/j.biomaterials.2018.05.049 ↗
9. 10.5214/ans.0972.7531.22040410.5214/ans.0972.7531.220404 ↗
10. 10.3727/096368912X64048410.3727/096368912X640484 ↗
11. 10.3727/096368909X47727310.3727/096368909X477273 ↗
12. 10.2174/1574888X1466619082314442410.2174/1574888X14666190823144424 ↗
13. 10.1002/stem.57010.1002/stem.570 ↗
14. 10.1089/neu.2014.346410.1089/neu.2014.3464 ↗
15. 10.3727/00000000678398160210.3727/000000006783981602 ↗
16. 10.1002/stem.236410.1002/stem.2364 ↗
17. 10.1089/neu.2009.094810.1089/neu.2009.0948 ↗
18. 10.3390/ijms2119703110.3390/ijms21197031 ↗
19. 10.1002/aoc.626910.1002/aoc.6269 ↗
20. 10.1166/jbn.2019.271510.1166/jbn.2019.2715 ↗
21. 10.1039/D1RA00861G10.1039/D1RA00861G ↗
22. 10.1039/D0BM00431F10.1039/D0BM00431F ↗
23. 10.1016/j.biomaterials.2017.05.02410.1016/j.biomaterials.2017.05.024 ↗
24. 10.1016/j.actbio.2019.01.05610.1016/j.actbio.2019.01.056 ↗
25. 10.1016/j.ijbiomac.2020.02.23010.1016/j.ijbiomac.2020.02.230 ↗
26. 10.1177/039139881986098510.1177/0391398819860985 ↗
27. 10.3390/ijms2203149910.3390/ijms22031499 ↗
28. 10.1016/j.carbpol.2020.11700510.1016/j.carbpol.2020.117005 ↗
29. 10.1177/088532821774175710.1177/0885328217741757 ↗
30. 10.1016/j.ijbiomac.2015.02.02110.1016/j.ijbiomac.2015.02.021 ↗
31. 10.1016/j.bbrc.2019.04.13710.1016/j.bbrc.2019.04.137 ↗
32. 10.1039/C9TB01929D10.1039/C9TB01929D ↗
33. 10.1021/acsami.8b1256210.1021/acsami.8b12562 ↗
34. 10.1021/acsbiomaterials.0c0069810.1021/acsbiomaterials.0c00698 ↗
35. 10.1016/j.ijbiomac.2018.11.02910.1016/j.ijbiomac.2018.11.029 ↗
36. 10.1021/am508319h10.1021/am508319h ↗
37. 10.1021/bm034327e10.1021/bm034327e ↗
38. 10.1016/j.ijbiomac.2017.06.01910.1016/j.ijbiomac.2017.06.019 ↗
39. 10.1006/exnr.1996.009810.1006/exnr.1996.0098 ↗
40. 10.1177/096368971878030910.1177/0963689718780309 ↗
41. 10.1002/jcp.2411410.1002/jcp.24114 ↗
42. 10.1039/c3tb21582b10.1039/c3tb21582b ↗
43. 10.3171/FOC.2008.25.11.E210.3171/FOC.2008.25.11.E2 ↗
44. 10.1002/jbm.a.3455110.1002/jbm.a.34551 ↗
45. 10.3727/096368910X49261610.3727/096368910X492616 ↗
46. 10.1038/sj.sc.310206310.1038/sj.sc.3102063 ↗
47. 10.1016/j.ijbiomac.2018.05.17510.1016/j.ijbiomac.2018.05.175 ↗
48. 10.1016/j.progpolymsci.2007.05.01310.1016/j.progpolymsci.2007.05.013 ↗
49. 10.1038/nprot.2011.37910.1038/nprot.2011.379 ↗
50. 10.1016/j.addr.2009.07.00510.1016/j.addr.2009.07.005 ↗
51. 10.1161/STROKEAHA.111.64622410.1161/STROKEAHA.111.646224 ↗
52. 10.1007/s10867-009-9157-910.1007/s10867-009-9157-9 ↗